USA flag logo/image

An Official Website of the United States Government

Search


Download to spreadsheetPrint
Displaying 1026 – 1050 of 1255 Awards
Company: SENSOR TECHNOLOGIES, INC. Agency/Program/Year/Phase: HHS / SBIR / 2002 / 2
Abstract: This Phase II SBIR involves the testing of a minimally invasive glucose sensor in vivo. Diabetes is an increasingly common lifelong disease and is associated with many complications. It is responsible for an estimated 10-15 percent of all health care expenditures. Effective… more
Company: ACELL, INC. Agency/Program/Year/Phase: HHS / SBIR / 2001 / 1
Abstract: DESCRIPTION (Unedited Applicant's Abstract):When people with diabetes reach end-stage renal disease they must undergo either dialysis or transplantation. About 200,000 Americans need artificial kidney machines to stay alive. These machines rely on sterile… more
Company: ADENOSINE THERAPEUTICS, LLC Agency/Program/Year/Phase: HHS / SBIR / 2001 / 1
Abstract: …,3-dipropyl-xanthine (CPX). Aims 3 and 4 of this proposal are designed to prove that A2B adenosine receptor blockade improves insulin sensitivity in rat models of insulin resistance. There is a great need for improved therapies to treat type II diabetes… more
Company: AFFERENT CORPORATION Agency/Program/Year/Phase: HHS / SBIR / 2001 / 1
Abstract: … phenomenon in which slight amounts of noise imparted to a system actually increase its sensitivity to weak stimuli. SR has been shown to produce a demonstrable effect in human sensory cells. In both healthy young and clinical subjects - elderly, diabetics, and… more
Company: AFFERENT CORPORATION Agency/Program/Year/Phase: HHS / SBIR / 2001 / 1
Abstract: … (SR), a counterintuitive phenomenon in which slight amounts of environmental noise actually increase the discernability of signals or stimuli, produces a demonstrable effect in human sensory cells. In both healthy young and clinical subjects- elderly, diabetics, and stroke… more
Company: AFFERENT CORPORATION Agency/Program/Year/Phase: HHS / SBIR / 2001 / 1
Abstract: … phenomenon in which slight amounts of noise imparted to a system actually increase its sensitivity to weak stimuli. SR has been shown to produce a demonstrable effect in human sensory cells. In both healthy young and clinical subjects-elderly, diabetics, and… more
Company: ARTECEL SCIENCES, INC. Agency/Program/Year/Phase: HHS / SBIR / 2001 / 1
Abstract: … adipose tissues and has an international reputation in this field. There is an unmet medial need for new technologies to create implant adipose tissues. Lipodystrophy patients lose subcutaneous fat, leading to life threatening diabetes. Creating… more
Company: Artium Technologies, Inc. Agency/Program/Year/Phase: HHS / SBIR / 2001 / 1
Abstract: DESCRIPTION: Phenotyping involves quantifying the vast array of molecular components that make up complex organisms. This proposal concerns nanobarcodes, a potentially revolutionary new technology platform for phenotyping. Nanobarcodes are free-standing,… more
Company: BioHybrid Technologies Inc. Agency/Program/Year/Phase: NSF / SBIR / 2001 / 1
Abstract: … applications of this project are expected to be immediate and significant. The final refinement in BioHybrid Technologies' microreactor technology is likely to lead to substantial improvements in treatment for a large number of human diseases including diabetes,… more
Company: ELECTROSONICS MEDICAL INC Agency/Program/Year/Phase: HHS / SBIR / 2001 / 1
Abstract: … the mechanical factors leading to pressure ulcers from the operating room environment. Over 40 million surgical procedures are performed annually in the US, of which a significant percentage involves a surgical population at risk of developing pressure ulcers (diabetic,… more
Company: ELECTROSONICS MEDICAL INC Agency/Program/Year/Phase: HHS / SBIR / 2001 / 1
Abstract: Diabetes mellitus is the sixth leading cause of death by disease in the United States, afflicting approximately 16 million people. Currently, there is no cure. The disease is treated by regular, life-long injections of insulin at a large cost to patients, both economically and… more
Company: BIOMEDICAL DEVELOPMENT CORPORATION Agency/Program/Year/Phase: HHS / SBIR / 2001 / 1
Abstract: DESCRIPTION (provided by applicant): The goal of this project is to demonstrate the feasibility of using a novel technology as a dual purpose wound dressing and drug delivery vehicle for the treatment of wounds associated with early stage diabetic foot… more
Company: BIOMEDICAL RESEARCH MODELS, INC. Agency/Program/Year/Phase: HHS / SBIR / 2001 / 1
Abstract: N/A
Company: BIOMEDICAL RESEARCH MODELS, INC. Agency/Program/Year/Phase: HHS / SBIR / 2001 / 2
Abstract: N/A
Company: BIOMEDICAL RESEARCH MODELS, INC. Agency/Program/Year/Phase: HHS / SBIR / 2001 / 1
Abstract: … model with spontaneous autoimmune disease. In Phase 1 we will establish a foundation colony of LEW.1WR1 rats and begin genetic crosses to introgress traits from BBDR/Wor and LEW.1WR strains. This should increase the incidence of spontaneous diabetes and may… more
Company: C AND L INSTRUMENTS, INC. Agency/Program/Year/Phase: HHS / SBIR / 2001 / 1
Abstract: Diabetic retinopathy, the leading cause of blindness among working-age Americans, is characterized by increased retinal microvascular permeability which results in the formation of lipid exudates, macular edema and blindness. … more
Company: CLINICIAN SUPPORT TECHNOLOGY, INC. Agency/Program/Year/Phase: HHS / SBIR / 2001 / 1
Abstract: … high costs result from access barriers (physical, convenience, or genographic), information failure, poor coordination of care, maldistribution of provider resources, and uneven quality. In addition to high-risk newborns, we believe that patients with cancer, diabetes,… more
Company: COMPACT MEMBRANE SYSTEMS, INC. Agency/Program/Year/Phase: HHS / SBIR / 2001 / 1
Abstract: Diabetic foot complications result in over 67,000 lower extremity amputations annually and cause more hospitalizations than any other single complication of diabetes. Foot wounds precede 84% of these amputations and usually occur when patients with diabetes have peripheral… more
Company: CUBIST PHARMACEUTICALS, INC. Agency/Program/Year/Phase: HHS / SBIR / 2001 / 1
Abstract: …. Gram-negative pathogens pose a serious health threat as they can be the causative agents of life-threatening conditions such as septicemia (Escherichia coli), meningitis (Haemophilus influenzae) or pyrogenic infections in burn patients and diabetics… more
Company: DBAZA, INC. Agency/Program/Year/Phase: HHS / SBIR / 2001 / 1
Abstract: N/A
Company: DBAZA, INC. Agency/Program/Year/Phase: HHS / SBIR / 2001 / 2
Abstract: N/A
Company: DEXCOM, INC. Agency/Program/Year/Phase: HHS / SBIR / 2001 / 1
Abstract: The NIH sponsored Diabetes Control and Complications Trial clearly demonstrates that near normalization of blood glucose dramatically slows the onset of the devastating complications of diabetes. However the continuous long-term tracking of glucose needed to achieve this tight… more
Company: DIAPEDIA, LLC Agency/Program/Year/Phase: HHS / SBIR / 2001 / 1
Abstract: DESCRIPTION (Adapted from the Investigator's Abstract): Gastrointestinal (GI) ulceration and hemorrhage is a major health problem in our country representing billions of dollars in health care costs and lost revenues from work place. Despite sophisticated therapeutic agents, the… more
Company: FLEXTECH SYSTEMS, INC. Agency/Program/Year/Phase: HHS / SBIR / 2001 / 1
Abstract: …ts and a central control station in addition to the voice communications expected with typical intercoms. Several examples utilizing this digital information are discussed in the proposal. We will specifically study one application associated with tracking the status of diabetic… more
Company: GENETEX, INC. Agency/Program/Year/Phase: HHS / STTR / 2001 / 1
Abstract: DESCRIPTION (Scanned from the Applicant's Abstract): Obesity is a major risk factor for diabetes mellitus (type 2; NIDDM). Fat cells secrete both diabetes promoting molecules (fatty acids; TNF-alpha) and at least one molecule that may be… more
Displaying 1026 – 1050 of 1255 Awards
Narrow Your Search
By Agency
By Year
By Phase
By Program
By State
By Company Ownership
By Company
HELP FOR NARROW YOUR SEARCH

Search Options

There are several categories such as “By Agency”, “By Year”, “By State” etc. Select a checkbox within a category to refine your search results.

Each of your selections is listed in the “Narrow Search Filters” bar. You can uncheck these selections to remove them.


Search for Either Criteria

When you select multiple values within a category, the results will include values that match either of the selections. For example, selecting “2005” and “2007” in the “By Year” category will display results that include either 2005 OR 2007 in the results.


Narrowing the Search Results

You can refine your search results across categories. To narrow down your results, select multiple values across different categories. The results will only include values that match the selections across the categories. For example, selecting “2005” in the “By Year” category and “NASA” in the “By Agency” category will only display the results that contain both “2005” AND “NASA” in the results.